[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:endometrial-adenocarcinoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":35,"states":36},"Endometrial Adenocarcinoma",4,[7,15,22,29],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05112601","Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma",[11],"Phase 2","RECRUITING","2026-08-26T02:15:25.633039Z","2026-05-05T02:43:28.218693Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06399757","A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors",[19],"Phase 1\u002FPhase 2","2026-08-03T03:48:46.663572Z","2026-05-05T02:43:27.110534Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":27,"content_modified":28},"NCT05841563","Clinical Trial of PM54 in Advanced Solid Tumors Patients.",[26],"Phase 1","2026-08-26T02:15:18.897219Z","2026-05-05T02:43:26.706220Z",{"nct_id":30,"title":31,"phases":32,"status":12,"updated_at":33,"content_modified":34},"NCT07705035","DBC-664 in Adult Patients With Solid Tumors Associated",[26],"2026-08-26T02:17:43.321968Z","2026-07-19T19:36:05.086969Z",[],[37,41],{"state":38,"count":39,"slug":40},"Michigan",3,"michigan",{"state":42,"count":39,"slug":43},"Texas","texas"]